DENVER, March 30, 2020 /PRNewswire/ -- CBD of Denver, Inc. (OTC:CBDD), a full-line CBD  / Hemp oil company ("CBDD") that sells Black Pearl CBD / Hemp Products and the owner of CBD Social Network, is pleased to announce the product release of Black Pearl CBD Immune Support and Black Pearl CBD Hand Sanitizer.

HONOLULU, March 30, 2020 /PRNewswire/ -- Cardax, Inc. (OTCQB:CDXI) reported its 2019 results. Highlights:CHASE Clinical Trial. On September 23, 2019, the Company

TAMPA BAY, Fla., March 30, 2020 /PRNewswire/ -- KnowBe4, the provider of the world's largest security awareness training and simulated phishing platform, today announced it has discovered a new type of phishing scam warning people that they've come into contact with a friend/colleague/family member who has been infected with the coronavirus. The email instructs them to d

SOUTHFIELD, Mich., March 30, 2020 /PRNewswire/ -- Lear Corporation (NYSE: LEA), a global automotive technology leader in Seating and E-Systems, has added capacity at its AccuMED production facility, which specializes in the manufacturing of medical products, to produce protective masks to combat the COVID-19 pandemic.

INDIANAPOLIS, March 30, 2020 /PRNewswire/ -- Springbuk, a health intelligence software company, today announced its ability to

LUND, Sweden, March 30, 2020 /PRNewswire/ -- Immunovia invites you to a teleconference (in English) for all stakeholders and media on Wednesday, April 1, 2020 at 16:30 CET. Mats Grahn, CEO will present an update on the company's COVID-19 response as well as an update on the

FALLS CHURCH, Va., March 30, 2020 /PRNewswire/ -- On Thursday, Apr. 2, 2020, at 2 p.m. ET, Worldwide Assurance for Employees of Public Agencies (

NEW HAVEN, Conn., March 30, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced positive topline results in its randomized, placebo-controlled pivotal clinical trial (NCT03732638) evaluating the efficacy and safety of oral rimegepant 75 mg for the preventive treatment of migraine in both episodic and chronic migraine patients. T

MARINA DEL REY, Calif., March 30, 2020 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that, following a vote in favor of the transaction by more than 99% of the Armata shareholders that vote

DOYLESTOWN, Pa., March 30, 2020 /PRNewswire/ -- Diverse Biotech, Inc. www.diversebiotech.com has announced it has signed an initial partnership agreement with The Preston Robert Tisch